Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Master of Science Candidate
EF 2018-19
Résumé
Chronic neuropathic pain is a debilitating condition that affects around 20% of Canadians but effective treatments are lacking. To develop treatments, we must understand the mechanisms underlying chronic pain at the central pain processing site – the spinal cord. Recent studies have identified that autophagy, a cellular degradation process, is impaired in spinal cord neurons during chronic pain. However, little is known about the upstream mechanisms that inhibit autophagy or the function of autophagy in pain processing, which is the focus of my proposal.
Aim 1 is to identify the receptors responsible for suppressing autophagy during pain and test whether reversing their action can reduce pain. Three of the candidate receptors I will test are TrkB, mGluR1, and mGluR5 because they have been linked to autophagy inhibition in different nervous system diseases, though their involvement in autophagy regulation has yet to be studied in the spinal cord or in the context of pain. The results of these experiments may identify specific molecular pathways to target for treating chronic pain.
Aim 2 is to elucidate how impaired autophagy leads to pain sensitization by studying the biophysical properties of spinal cord neurons. Pain is associated with increased excitability of spinal cord neurons by increasing current flow through the NMDAR ion channels. Thus, I will test whether inhibiting autophagy increases the excitability of these neurons by measuring NMDAR currents.
My studies will provide a greater understanding of the mechanisms by which the autophagy pathway regulates pain signalling. Since autophagy-modulating drugs are already used clinically to treat a variety of conditions, my findings could lead to the repurposing of such drugs as potential treatment for chronic pain.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
406345
Name
Tam Theresa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Master of Science Candidate
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autophagy; Cell Signalling; Nmda Receptors; Pain
Abstract
Chronic neuropathic pain is a debilitating condition that affects around 20% of Canadians but effective treatments are lacking. To develop treatments, we must understand the mechanisms underlying chronic pain at the central pain processing site – the spinal cord. Recent studies have identified that autophagy, a cellular degradation process, is impaired in spinal cord neurons during chronic pain. However, little is known about the upstream mechanisms that inhibit autophagy or the function of autophagy in pain processing, which is the focus of my proposal.
Aim 1 is to identify the receptors responsible for suppressing autophagy during pain and test whether reversing their action can reduce pain. Three of the candidate receptors I will test are TrkB, mGluR1, and mGluR5 because they have been linked to autophagy inhibition in different nervous system diseases, though their involvement in autophagy regulation has yet to be studied in the spinal cord or in the context of pain. The results of these experiments may identify specific molecular pathways to target for treating chronic pain.
Aim 2 is to elucidate how impaired autophagy leads to pain sensitization by studying the biophysical properties of spinal cord neurons. Pain is associated with increased excitability of spinal cord neurons by increasing current flow through the NMDAR ion channels. Thus, I will test whether inhibiting autophagy increases the excitability of these neurons by measuring NMDAR currents.
My studies will provide a greater understanding of the mechanisms by which the autophagy pathway regulates pain signalling. Since autophagy-modulating drugs are already used clinically to treat a variety of conditions, my findings could lead to the repurposing of such drugs as potential treatment for chronic pain.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tam, Theresa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~